Everbloom Fertility Solutions LLC – Trademark Portfolio

Entity Type: 16

Everbloom Fertility Solutions LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 3 Nice Classification classes. Currently, 0 trademarks are registered and 2 are pending. The owner is based in Newark, CA.

6167 Jarvis Ave

Ste #118

Newark, CA 94560

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Everbloom Fertility Solutions LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Everbloom Fertility Solutions LLC have?

Everbloom Fertility Solutions LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 pending, 1 abandoned.

What trademark classes does Everbloom Fertility Solutions LLC file in?

Everbloom Fertility Solutions LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What is Everbloom Fertility Solutions LLC's trademark registration success rate?

Everbloom Fertility Solutions LLC has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.